C79.9 Secondary malignant neoplasm of unspecified site
C79.9 is a risk-adjusting diagnosis under CMS-HCC and RxHCC models. Create a free account to see model versions, RAF contribution, and AI-powered HCC suppression analysis.
Get what a quick lookup can't: the AI assistant for official-guideline questions, HCC risk-adjustment mappings (CMS-HCC V24/V28, RxHCC), FDA drug indications, and AHA Coding Clinic references for C79.9.
The ICD-10-CM code for Secondary malignant neoplasm of unspecified site is C79.9 (FY2026). It is a billable, claim-ready diagnosis code.
Classification
- Chapter
- 2: Neoplasms (C00-D49)
- Section
- C76-C80: Malignant neoplasms of ill-defined, other secondary and unspecified sites (C76-C80)
- Category C79
- 33 codes (24 billable)
- FY2026 Status
- Stable since FY2024
Also Known As
ICD-10-CM Alphabetic Index entries that lead to C79.9:
- Disease, diseased › metastatic
- Metastasis, metastatic › disease
Inclusion Terms
- Metastatic cancer NOS
- Metastatic disease NOS
U.S. Hospital Utilization
- An estimated 50,615 U.S. inpatient stays in 2023 included C79.9 among the documented diagnoses.
- 460 stays listed it as the principal diagnosis.
Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.
Official Coding Guidelines
Tx of primary site (TOC entry)a. Admission/Encounter for treatment of primary site ............................................................. 33
Tx of secondary site (TOC entry)b. Admission/Encounter for treatment of secondary site .......................................................... 33
Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026
References
Cite This Page
Reference C79.9 with the canonical source and edition:
C79.9 — Secondary malignant neoplasm of unspecified site. ICD-10 Coding Pro (ICD-10-CM FY2026). https://icd10codingpro.com/codes/C79.9
Canonical URL: https://icd10codingpro.com/codes/C79.9